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Abstract
Background: During pregnancy, myometrial gene and protein expression is tightly regulated to accommodate
fetal growth, promote quiescence and ultimately prepare for the onset of labour. It is proposed that changes in
calcium signalling, may contribute to regulating gene expression and that nuclear factor of activated T-cell (NFAT)
transcription factors (isoforms c1-c4) may be involved. Currently, there is little information regarding NFAT
expression and regulation in myometrium.
Methods: This study examined NFAT isoform mRNA expression in human myometrial tissue and cells from
pregnant women using quantitative PCR. The effects of the Ca2+ ionophore A23187 and in vitro stretch (25 %
elongation, static strain; Flexercell FX-4000 Tension System) on NFAT expression were determined in cultured
human myometrial cells.
Results: Human myometrial tissue and cultured cells expressed NFATc1-c4 mRNA. NFATc2 gene expression in cultured
cells was increased in response to 6 h stretch (11.5 fold, P < 0.001, n = 6) and calcium ionophore (A23187, 5 μM)
treatment (20.6 fold, P < 0.001, n = 6). This response to stretch was significantly reduced (90 %, P < 0.001, n = 10) in the
presence of an intracellular calcium chelator, BAPTA-AM (20 μM).
Conclusions: These data suggest that NFATc2 expression is regulated by intracellular calcium and in vitro stretch, and
that the stretch response in human myometrial cells is dependent upon intracellular calcium signalling pathways. Our
findings indicate a potentially unique role for NFATc2 in mediating stretch-induced gene expression per se and warrant
further exploration in relation to the mechanisms promoting uterine smooth muscle growth in early pregnancy and/or
labour.
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Background
It is widely accepted that a rise in the availability of intra-
cellular Ca2+, through the up-regulation of calcium influx
and release pathways, underpins the development of force-
ful uterine contractions during labour [1–3]. However,
there is little understanding of how changes in calcium
signalling in response to mechanical signals could drive
changes in gene and protein expression in myometrium
during early pregnancy or prior to labour to influence
uterine development, growth and/or contractility.
Over the course of pregnancy, the myometrium must
grow in size to accommodate the fetus and amniotic
fluid, resulting in a 20-fold expansion in size and at term
must become contractile in preparation for labour [4].
Animal models have shown that myometrial cells undergo
a program of differentiation phases consisting of an early
proliferative phase during which cells are hyperplastic, an
intermediate synthetic phase consisting of cell hyper-
trophy, a third phase at around mid-gestation during
which myometrial cells stop growing, contractile mecha-
nisms are up-regulated and pro-quiescent factors are
down-regulated and a final phase at the end of gestation
in which cells switch to being highly active and committed
to labour [5–8]. Studies that have measured uterine weight
at opportune times in human pregnancy indicate that the
human myometrium undergoes a period of rapid growth
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between the non pregnant state and the 20th week of
pregnancy and subsequently, and in contrast to animals,
continues to grow at a slower rate until close to term [9, 10].
The link between exogenous signals such as mechan-
ical stretch and endocrine signals and intracellular
events to drive human uterine smooth muscle cell
hyperplasia in early-mid pregnancy and hypertrophy in
human myometrium are not clearly defined. In other cell
types and smooth muscles, however, intracellular cal-
cium signals are well known to regulate gene expression
and growth through downstream activation and modula-
tion of transcription factors [11–14] but in human preg-
nant myometrium, there is little documented about the
role of Ca2+-sensitive transcription factors.
An important family of Ca2+-sensitive transcription
factors are the nuclear factor of activated T-cells (NFAT)
which consist of 4 isoforms, nuclear factor of activated
T-cells, cytoplasmic, calcineurin-dependent 1 (NFATc1),
NFATc2, NFATc3 and NFATc4. This group of transcrip-
tion factors also include the Ca2+/calcineurin-insensitive
NFAT5. NFAT protein activation is initiated by the
phosphatase calcineurin, which is controlled by Ca2+
and calmodulin [15, 16]. Activated calcineurin dephos-
phorylates cytoplasmic NFAT proteins allowing rapid
translocation of NFAT to the nucleus [16, 17] and bind-
ing to DNA. Other nucleoproteins can bind coopera-
tively with NFAT, including members of the AP-1
transcription factor [18].
NFAT transcription factors were originally identified
to play a role in immune cell function, but have since
been shown to be present in smooth muscle cell types,
including human myometrial artery smooth muscle
[19], mouse ileal smooth muscle [20] and mouse cere-
bral artery smooth muscle [21] and have been impli-
cated in the regulation of genes that control cell cycle
progression, cell development, cell differentiation and
angiogenesis [22–26].
There are very few reports of NFAT expression in rela-
tion to myometrium. Tabata et al. [27] identified gesta-
tional changes in NFAT isoform c1, c3 and c4 mRNA
expression in pregnant mouse uterus and more recently;
Pont et al. [28] demonstrated oxytocin-induced NFAT
nuclear translocation which mirrored pulses of oxytocin
in a frequency-dependent manner in non-pregnant human
myometrial cells.
The aim of this study was to identify NFAT isoforms in
pregnant human myometrial tissue and primary myome-
trial cells. The regulation of NFAT mRNA expression by
intracellular calcium was also investigated, as there are
reports in other cell types that NFATc1 gene expression is
up-regulated by rises in intracellular Ca2+ [29–34]. As
mechanical strain/stretch, pregnancy and labour associ-
ated stimulus for uterine smooth muscle hyperplasia and
hypertrophy may increase intracellular calcium [35–38]
we also explored the effect of in vitro stretch on myome-
trial NFAT expression.
Methods
Subjects
Human myometrial biopsies were obtained at Caesarean
section with informed written consent and institutional
Ethics Committee approval (Guy’s and St Thomas’ Hospital
NHS Trusts, London, UK; Office of Medical Bioethics,
University of Calgary). Biopsies from the upper edge of the
lower segment incision were obtained from pregnant
women at the time of elective caesarean section (at term
prior to labour), none of the women had underlying med-
ical conditions (reasons for elective caesarean section at
37–40 weeks were: maternal request, breech presentation,
previous caesarean section, fetal cardiac anomaly detected
antenatally, stress incontinence, previous 3rd degree tear or
placenta praevia). In addition, lower segment human myo-
metrium was also obtained from four groups of women at
the time of caesarean section (LSCS) under the conditions
of preterm no labour (PTNL; 29.2 ± 1.7 weeks’, myome-
trium samples from n = 5 women, reasons for elective
caesarean section were intrauterine growth restriction or
preeclampsia/pregnancy induced hypertension), preterm
with labour (PTL; 30.0 ± 2.1 weeks’, samples from n = 4
women, reasons for caesarean section were breech presen-
tation, previous caesarean section and increased fetal heart
rate detected during labour), term no labour (TNL; 39.5 ±
0.4 weeks’, samples from n = 6 women, reason for caesarean
section was previous caesarean section or breech) and term
with labour (TL; 39.1 ± 0.6 weeks’, samples from n = 6
women, reasons for caesarean section were presented in
early labour and elected to have section, failure to progress
and/or fetal distress in labour). Whole myometrial tissue
was either snap frozen and stored at −80 °C or used imme-
diately for cell culture.
Cell culture
Myometrial cells were dispersed enzymatically from tissue
biopsies as described previously from term non-labouring
(TNL) women [39]. Briefly, small segments of myome-
trium were dissected and chopped into 1–2 mm3 pieces
and incubated for 30–40 min in Dulbeccos modified
Eagles medium (DMEM) containing 1 mg/ml collagenase
1A, 1 mg/ml collagenase XI plus 0.1 % bovine serum albu-
min (BSA), penicillin (50 units/ml), and streptomycin
(50 mg/ml). Cells were dislodged using a Pasteur pipette
and then filtered through a 45 μm sterile filter, and washed
twice in DMEM containing 10 % fetal calf serum (FCS) by
centrifugation (450 × g 5 min). The cell pellet was sus-
pended in DMEM supplemented with 10 % FCS, penicillin
(25 units/ml), and streptomycin (25 mg/ml). Primary
myocytes were seeded in T25 culture flasks and incubated
at 37 °C in a humidified atmosphere of 95 % air/5 % CO2.
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Routine immunofluorescent labeling of cells with alpha-
actin and calponin monoclonal antibodies was routinely
performed to verify the purity of myocyte cultures.
After the first 2 days of culture, media was replaced
with DMEM supplemented with 5 % FCS, penicillin
(25 units/ml), and streptomycin (25 mg/ml). The medium
was changed every 2 days until cells were ~80 % conflu-
ent. Cells were used for experimentation at passage 2 (P2)
in order to have enough material for in vitro the stretch
protocol.
Exposure of human myometrial cells to A23187 Ca2+
ionophore treatment
Human myometrial cells (P2) were cultured in six well
culture plates in 3 ml DMEM plus 5 % FCS (Corning)
until approximately 80 % confluent. Following replenish-
ment of media (24 h prior to experimentation, 5 % FCS),
cells were exposed to A23187 Ca2+ ionophore (5 μM,
Sigma-Aldrich, UK) or vehicle control (0.1 % dimethyl
sulfoxide, Sigma-Aldrich, Gillingham, UK) for 6 or 14 h
at 37 °C in a humidified atmosphere of 95 % air/5 %
CO2. At the end of the experiment, cells were rinsed
with phosphate-buffered saline (PBS) and collected for
RNA/protein extraction.
Exposure of myometrial cells to tonic mechanical strain
A method similar to that used in the present has been
described previously by us and others [40, 41]. Pregnant
human myometrial cells (P2) were cultured in six well
flexible-bottom culture plates pre-coated with collagen
type I (Flexcell International Corp., Hillsborough, USA)
in 3 ml DMEM plus 5 % FCS until approximately 80 %
confluent. Media was replaced 24 hours before cells
were subjected to 25 % tonic mechanical stretch for 6 h
using a strain unit (Flexercell FX-4000 Tension system,
Flexcell International Corp., Hillsborough, USA) housed
in a cell culture incubator (37 °C, 95 % air, 5 % CO2).
Time matched control cells were grown on the same
flexible-bottomed culture plates, but were not stretched.
In order to test the impact of buffering of intracellular
Ca2+ whilst stretching, cells were pre-incubated for 1 h
with BAPTA-AM (20 μM, Sigma-Aldrich, Gillingham,
UK) or vehicle control (0.1 % dimethyl sulfoxide) before
commencement of the 6 h tonic mechanical strain proto-
col. Subsequent to treatments, cells were washed with
PBS and RNA extracted.
RNA isolation from human myometrial tissue and human
myometrial cells
Total RNA was extracted from human myometrial tissue
from term non-labouring (TNL) women (~30 mg per
sample) was homogenized using a TissueLyser (Qiagen,
Crawley, UK) in Trizol® (Invitrogen, Paisley, UK) as per
manufacturer’s recommendations. RNA was extracted
from cultured myometrial cells using the RNeasy mini
kit (Qiagen, UK) according to the manufacturer’s in-
structions. RNA samples were quantified using a
Thermo Scientific NanoDrop ND-1000 spectrophotom-
eter (Labtech, International Ltd, East Sussex, UK). The
absorbance of each sample at 260 nm was used to cal-
culate RNA concentration and an optical density 260/
280 ratio was calculated to determine RNA purity. An
OD 260/280 ratio of more than 1.8 was considered
acceptable [42].
Quantitative real-time PCR
cDNA was synthesised from 500 ng RNA using 0.25 μg
random hexanucleotide primers (Promega, Southampton,
UK) and 200 IU Superscript III (Invitrogen, Paisley, UK).
Quantitative real-time PCR was performed with the use of
SYBR Green chemistry (Bioline, London, UK) and a
RotorGene 6000 Sequence Detector (Qiagen, Crawley,
UK) using primer sets as listed in Table I. The PCR cycling
conditions were as follows: an initial denaturation step of
95 °C for 10 min, then 45 cycles of a programme consist-
ing of denaturation (95 °C, 15 s), annealing (60 °C, 30 s)
and extension (72 °C, 20 s). Melt curve analysis confirmed
a single product, and all products were sequenced to con-
firm identity. Negative reverse transcription reactions
were used routinely to assess genomic DNA contamin-
ation. Test samples were run in duplicate in parallel with
cDNA standards of known gene copy number abundance
(106 to 101 copies). Cycle threshold values were used for
analysis and abundance data was obtained for test samples
by the generation of a standard curve based on the quanti-
fied cDNA. Abundance data for NFAT isoform expression
for cell studies, Figures 1, 2, 4 and 5 were expressed relative
to the geometric mean of a panel of housekeepers (glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH), β-actin
and β-2 microglobulin) as determined by GeNorm soft-
ware [43] and for tissues only GAPDH was used due to
limited cDNA availability and previous assessment which
showed GAPDH was the most stable housekeeper for
tissue analysis (Fig. 6). All data were log10 transformed.
Preparation of whole cell protein lysates
Myometrial whole cell lysates were prepared by remov-
ing culture medium and rising twice with ice-cold PBS.
The cells were then aspirated to dryness and 100 μl of
lysis buffer (10 mM of Hepes-KOH [pH 7], 1 mM of di-
thiothreitol, 1 % nonident-P40, and protease-inhibitor
cocktail [COMPLETE tablets; Boehringer-Mannheim
Biochemicals, Lewes, Sussex, U.K.]) was added to each
well and incubated on ice for 5 min. Cells were then
scraped and the lysate removed and placed in to a 1.5 ml
microfuge tube and centrifuged for 1 minute at
13,000 rpm to remove any cell debris. Tissue and whole
cell lysate protein content was quantified using a Thermo
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Scientific NanoDrop ND-1000 spectrophotometer. Lysates
were then diluted 1:1 with x 2 Laemmli sample buffer
(Sigma) then boiled at 95 °C for 5 min. Samples were then
stored at −20 °C until required, when they were thawed,
then re-boiled for 5 min at 95 °C and centrifuged at
12470 g for 1 min prior to electrophoresis.
SDS-PAGE and Western Immunoblotting
Whole cell lysate proteins were separated using 10 %
Tris-Glycine precast gels (Invitrogen) using the XCell
SureLock™ Mini-Cell system (Invitrogen). Following elec-
trophoresis, proteins were transferred to Immobilion™-P
transfer membrane (Millipore) using the XCell SureLock™
Mini-Cell blotting module wet transfer blotting system.
After transfer of proteins to the membrane, non-specific
sites were blocked by soaking the membrane in 100 %
methanol for 10 s and then allowing the membrane to dry
completely for approximately 15 min. Membranes were
then incubated for at least 5 h with maximum speed of
agitation at room temperature or overnight at 4 °C with
the appropriate NFATc2 primary antibody (Abcam:
AB2722) diluted 1:1000 or β-actin (Abcam: AB6276)
diluted 1:5000 in tris-buffered saline with tween (TBS-T:
50 mM Tris, 150 mM NaCl, 0.2 % (v/v) Tween-20,
pH 7.4) containing 10 % (w/v) BSA. Membranes were
then washed for 3 × 20 min in TBS-T. Following the incu-
bation of the membrane in a 1:10,000 dilution in TBS-T
of horseradish peroxidase (HRP)-conjugated goat anti-
mouse secondary antibody (BD Pharmigen) for 45 min,
Fig. 2 Effect of Ca2+ ionophore A23187 (5 μM) treatment on NFAT gene expression in pregnant human myometrial cells. Expression of NFAT
isoforms in cultured (P2) human myometrial cells at 0 h (baseline) and exposed to A23187 (blue line) for 6 h and in vehicle control (0.1 %
dimethyl sulfoxide) treated cells (black line). Data are expressed as mean ± SE log copy number [n = 6 cultures from myometrium biopsies taken
from 6 pregnant women undergoing caesarean section at term, normalised to GeNorm normalisation factor (NF)]. Comparison between change
in NFAT expression in A23187 and vehicle control treated cells from baseline to 6 h (*** P < 0.001)
Fig. 1 NFAT isoform expression profiles in pregnant human
myometrial tissue and cultured cells. NFAT isoform mRNA expression
in human myometrial tissue (blue bars, n = 6), primary (P0) human
myometrial cells (white bars, n = 6) and cultured (P2) human
myometrial cells (grey bars, n = 6). Data are expressed as mean ± SE
log copy number [normalised to GeNorm normalisation factor (NF)].
Comparison of NFAT isoform expression in myometrial tissue versus
P0 human myometrial cells and myometrial tissue versus P2 human
myometrial cells (* P < 0.05, *** P < 0.001). Comparison of NFATc2
isoform expression in P0 human myometrial cells versus P2 human
myometrial cells (P < 0.001)
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the membrane was washed a further 3 × 20 minutes in
TBS-T. Immunoreactive proteins were visualised using
enhanced chemiluminescence (ECL™) (Amersham) ac-
cording to the manufacturer’s instructions. Densitometric
quantification of immunoreactive bands was carried out
using BioRad Molecular Quantity One software, version
4.4.0. To verify equal protein loading, blots were also
probed with β-actin antibody.
Statistical analysis
Data were analysed using Stata 10.0 (Stata Corp., College
Station, USA). Differences between NFAT isoform expres-
sion in tissue and cells were assessed using linear regres-
sion. Results were expressed as ratios of the group means
with 95 % confidence intervals; mean gene expression ±
SEM is displayed graphically. The impact of experimental
interventions on gene expression in human myometrial
cells over time was estimated using linear regression on
the log-copy number with a fixed subject effect to adjust
for clustering and interaction tests were carried out where
necessary. Mean fold changes over time in gene expres-
sion are presented in the text with 95 % confidence inter-
vals; mean gene expression ± SEM at each time point is
displayed graphically. Significance for all data was taken at
P < 0.05. ‘n’ refers to the total number of cell cultures
(each originating from a biopsy from a different subject).
Results
NFAT mRNA expression in human myometrial tissue,
primary human (P0) myometrial cells and cultured (P2)
human myometrial cells
NFAT mRNA for all isoforms (c1-c4) was detected in
human myometrial tissue (n = 6). NFAT isoforms c1-c4
were also expressed in P0 (n = 6) and P2 (n = 6) human
myometrial cells, but NFATc1, NFATc2 and NFATc3 ex-
pression was suppressed in P0 and P2 human myome-
trial cells compared to myometrial tissue. NFATc2
expression was lower in P2 compared to P0 cells (95 %
CI: 71.4 to 91.7, P < 0.001). (Fig. 1).
Effect of Ca2+ ionophore A23187 treatment on NFAT gene
expression and protein in human myometrial cells
Application of the Ca2+ ionophore A23187 caused a
20.6 times (95 % CI: 7.6 to 55.6, P < 0.001, n = 6) in-
crease in NFATc2 gene expression over 6 h compared
to vehicle control (Fig. 2). There was no significant
effect of Ca2+ ionophore A23187 treatment on
NFATc1, NFATc3 or NFATc4 expression. Incubation
of human myometrial cells with Ca2+ ionophore
A23187 for 14 h significantly increased NFATc2 pro-
tein expression (p < 0.05, n = 6) (Fig. 3).
Effect of in vitro stretch on NFAT gene expression in
human myometrial cells
In vitro stretch of cultured (P2) human myometrial cells
caused an 11.5 times (95 % CI: 4.3 to 30.9, P < 0.001, n = 6)
increase in NFATc2 gene expression over 6 h compared to
non-stretched cells (Fig. 4). There was no effect of in vitro
stretch on the expression of any other of the NFAT
isoforms.
Impact of BAPTA-AM on NFATc2 gene expression in
stretched human myometrial cells
There was a small effect (1.9 fold, 95 % CI: 1.3 to 2.7, P <
0.05, n = 10) of BAPTA-AM on NFATc2 expression in
non-stretched cells (change from t = 0 h to t = 6 h) but not
in the vehicle control (Fig. 5), but there was no difference
between absolute NFATc2 mRNA expression in BAPTA-
AM treated cells compared to cells exposed to vehicle at
the 6 hour time point. NFATc2 gene expression was signifi-
cantly increased 11.0 times (95 % CI: 4.6 to 26.4, P < 0.001,
n = 10) in stretched cells, but there was a 90 % reduction
(95 % CI: 72.3 % to 96.4 %, P < 0.001, n = 10) in the effect
of stretch on NFATc2 gene expression in the presence of
BAPTA-AM.
NFATc2 mRNA expression in preterm and term human
myometrial tissue
NFATc2 mRNA expression was detected in myometrial
tissues taken from women delivering preterm and term
Fig. 3 Effect of Ca2+ ionophore A23187 (5 μM) treatment on NFATc2
protein expression in pregnant human myometrial cells. P2 human
myometrial cells were exposed to A23187 for 14 h. Representative
immunoblots are shown for NFATc2 and β-actin protein expression.
Data are expressed as mean ± SE arbitrary units normalised to
β-actin protein expression, n = 6. *P < 0.05 compared to
vehicle control
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gestations. There was no significant difference in tissues
taken from women prior to or during labour (Fig. 6).
Discussion
This study demonstrates the presence of mRNA for all
Ca2+ /calcineurin-dependent NFAT isoforms c1-c4 in
pregnant human myometrium and cultured cells. This is in
good agreement with previously a published report of
NFAT isoform expression in non-pregnant human myome-
trial cells [28]. However, the expression profile in human
myometrial tissue contrasts with NFAT expression profiles
in other smooth muscle tissue types, including human
myometrial artery, mouse ileal smooth muscle and mouse
cerebral artery smooth muscle in which NFATc2 has not
been detected [19–21]. Moreover, although NFATc2 has
been detected in smooth muscle from human and rat
aorta [44–46] as well as human myometrial arteries after
culture [19], the presence of NFATc2 in pregnant myome-
trial and cultured cells indicates a potentially important
role for NFATc2 in human myometrium.
All four isoforms, NFATc1-4, were expressed in human
myometrium tissue taken from women at term, but prior
to labour onset. In contrast, cultured (P0) human myome-
trial cells displayed an altered NFAT mRNA expression
profile compared to tissue, with NFATc1, c2 and c3 iso-
form expression significantly decreased in primary cells
that were cultured in media containing 5 % serum.
NFATc1 and NFATc3 gene expression remained stable fol-
lowing a further period of culture (until P2), but NFATc2
expression decreased further. The differences between
Fig. 5 Impact of BAPTA-AM on NFATc2 gene expression in cultured
(P2) pregnant human myometrial cells during a 6 h stretch period.
A) NFATc2 expression in non-stretched control cells (t = 0 to t = 6 h)
treated with BAPTA-AM (20 μM) (blue line) or vehicle control (0.1 %
dimethyl sulfoxide) (black line). B) NFATc2 expression in 6 h
stretched (25 % static strain) cells (t = 0 to t = 6 h) treated with
BAPTA-AM (blue line) or vehicle control (black line). Data are
expressed as mean ± SE log copy number [n =10, normalised to
GeNorm normalisation factor (NF)]. In non-stretched cells there was a
slight change in NFATc2 expression (# P < 0.05) from t = 0 h to t = 6 h
in BAPTA-AM treated cells, but there was no significant difference in
BAPTA-AM-treated versus vehicle control at t = 6 h. Both BAPTA-AM
treated and vehicle control treated cells under stretch demonstrated a
significant change in NFATc2 expression between t = 0 h to t = 6 h
(##, P = 0.001) but the effect of stretch was significantly greater in cells
in the absence of BAPTA-AM (** P < 0.001)
Fig. 4 Effect of in vitro stretch on NFAT gene expression in pregnant human myometrial cells. Expression of NFAT isoforms in cultured (P2)
human myometrial cells at 0 h (baseline) and exposed to 25 % in vitro strain (blue line) for 6 h and in non-stretched time-matched control cells
(black line). Data are expressed as mean ± SE log copy number [n = 6, normalised to GeNorm normalisation factor (NF)]. Comparison between
change in NFAT expression in stretched and non-stretched cells from baseline to 6 h (* P < 0.001)
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tissue and primary cells NFATc expression levels could
reflect the multicellular composition of myometrial tissue
(e.g. immune cells, vascular cells etc.) but alternatively, the
reduction in NFATc1, NFATc2 and NFATc3 gene expression
is more likely to be due to phenotypic changes induced by
the cell culture environment, and indicative that NFAT
genes can be modulated in human myometrial cells. In our
culture systems, cells are grown in the presence of 5 %
serum and receiving signals to promote hyperplasia, whereas
in myometrial tissue at term cells are no longer dividing [8].
Interestingly, the human myometrium cell culture (P2)
associated reduction in NFATc2 mRNA and protein ex-
pression was reversed by exposing the cells to myometrial
cells to Ca2+ ionophore A23187. This is of interest as
whilst NFATc1 has been previously demonstrated in im-
mune cells to be susceptible to gene regulation, NFATc2
mRNA and it associated protein has only been found to
be constitutively expressed in other tissues [30, 32, 34].
The explanation for this tissue-difference in isoform regu-
lation is unclear due to limited information on NFAT pro-
moter behaviour, but may reflect the dependency of
NFATc1 and NFATc2 isoform mRNA regulation on add-
itional factors that are specific to different cell types.
Our findings also show that prolonged in vitro mechan-
ical stretch increased NFATc2 expression in vitro after 6 h.
This should be investigated to see whether it occurs at
other time-points. Mechanical stretch has been implicated
as a signal for mediating gene expression prior to labour
onset; a mechanism for promoting contraction-associated
proteins [47], but is also a signal for promoting cellular
proliferation and growth [48–50]. Our data, therefore,
could indicate a contribution of NFAT regulated tran-
scription in human myometrial tissue during pregnancy
particularly at earlier gestations when cells are proliferat-
ing (as per our in vitro stretch model). However, it is
noted that in the small number of human myometrium
tissues studied NFATc2 mRNA expression remained rela-
tively stable at preterm and term gestations prior to and
after labour onset, and so the involvement of this isoform
in mediating changes associated with labour cannot be in-
ferred without further study. It is interesting to note, that
in mice NFATc1, 2 and 4 mRNAs have been reported to
increase during pregnancy, although these data were ob-
tained in an oxytocin receptor knock mouse model and
the mRNA data were not quantified [27].
The observation that stretch induced changes in NFATc2
expression are suppressed by BAPTA-AM further implies
that changes in intracellular calcium in response to stretch
are important in this response. The impact on NFATc2 re-
lated protein expression still requires examination. Under
non-stretch conditions, NFATc2 mRNA also increased
slightly in the BAPTA-AM treated cells over time, but the
expression level at 6 h was no different from the vehicle
control at this time point, suggesting that the change was
not biologically significant.
If these in vitro findings reflect responses in vivo then it
is possible that uterine stretch (or other pregnancy associ-
ated stimuli that induce increases in Ca2+) could contrib-
ute to induction of NFATc2 expression and/or activation
in myometrium in pregnant women. The translation and
functional impact of these Ca2+ and/or stretch induced re-
sponses in myometrium now require further confirmation
at the protein level. Ideally, studies looking at NFAT pro-
tein expression (and the other isoforms) and localisation
in human tissues at different stages of gestation, and in
cells, would shed further light other potential functional
contributions NFTAc2 or other isoforms make in regulat-
ing uterine smooth muscle growth and contractility in
pregnancy. We experienced difficulties with using anti-
bodies to distinguish different NFATc isoforms (data not
shown), which limited the scope of our study.
Investigations into the relationship of NFAT regulation
with other important myometrial transcription factors, for
example, NF-κB [51–55] and AP-1 would also be of interest
given their reported interactions in other cell types [56–61].
Conclusion
In summary, the study presents novel data concerning
NFAT mRNA expression and regulation by calcium in
human myometrium. Our findings also indicate a poten-
tial role for NFATc2 in mediating stretch-induced gene
expression per se. These warrant further exploration in
relation to the mechanisms promoting myometrial cell
proliferation/growth in pregnancy and contractility in
prior to labour. In particular a more focussed study of
NFATc2 protein function and translocation, using con-
focal imaging with immunohistochemistry and live cell
calcium sensitive dyes, in response to different intracel-
lular calcium and mechanical stretch signals is required.
Fig. 6 Effect of gestation and labour on NFATc2 gene expression in
human myometrial tissue. Data are expressed as mean ± SE log copy
number normalised to GAPDH. PTNL = 5, PTL = 4, TNL = 6, TL = 6
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